Find a Doctor

Areas of Expertise

Elite

Patent Ductus Arteriosus
Premature Infant

Distinguished

Advanced

Dr. Arne Ohlsson

University Of Toronto

Bio

Arne Ohlsson is in Toronto, Canada. Dr. Ohlsson is a global expert in Patent Ductus Arteriosus. They have been an author on 152 peer reviewed articles in the past 15 years. In particular, they have been an author on 26 peer reviewed articles regarding Patent Ductus Arteriosus. Dr. Ohlsson's top three areas of expertise are Patent Ductus Arteriosus, Premature Infant, Periventricular Leukomalacia, and Necrotizing Enterocolitis.

Areas of Expertise

Elite

Patent Ductus Arteriosus
Premature Infant

Distinguished

Advanced

Contact

600 University Avenue, M5g 1x5
Toronto, ON, CA

Latest Advances

Condition: Preterm and/or Low Birth Weight (LBW) Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Early versus Late Erythropoietin
Number of Patients: 0
Published — February 13, 2020

The study compared the outcomes between early versus late erythropoietin for preterm and/or low birth weight infants.

Condition: Preterm or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Early Erythropoiesis-Stimulating Agents (ESAs)
Number of Patients: 0
Published — February 13, 2020

This review of the literature assessed the safety and effectiveness of the use of erythropoiesis-stimulating agents (ESAs) in preterm and/or low birth weight infants.

Condition: Patent Ductus Arteriosus (PDA) in Preterm or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Ibuprofen
Number of Patients: 2843
Published — February 12, 2020

The purpose of this study was to determine the safety and effectiveness of ibuprofen treatment for closing patent ductus arteriosus (PDA) in preterm, low-birth-weight-, or preterm and low-birth-weight infants. The study compared ibuprofen use with indomethacin, other cyclo-oxygenase inhibitors, placebo, or no intervention.

Condition: Infection in Preterm and/or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Intravenous Immunoglobulin
Number of Patients: 5000
Published — January 30, 2020

The study researched the use of intravenous immunoglobulin in preventing infection in preterm and/or low birth weight infants.

Condition: Anemia in Preterm Or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Erythropoiesis-stimulating Agents
Number of Patients: 1651
Published — January 29, 2020

In this study, researchers evaluated the safety and effectiveness of erythropoiesis-stimulating agents for the treatment of anemia in preterm or low birth weight infants.

Condition: Pain in Newborns
Journal: The Cochrane database of systematic reviews
Treatment Used: Acetaminophen
Number of Patients: 728
Published — January 28, 2020

In this study, researchers evaluated the safety and effectiveness of acetaminophen for the prevention or treatment of pain in newborns.

Condition: Patent Ductus Arteriosus with Preterm and/or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Ibuprofen
Number of Patients: 1070
Published — January 28, 2020

This study tested the safety and efficacy of using ibuprofen to treat preterm and/or low birth weight infants with patent ductus arteriosus.

Condition: Preterm infants at risk for or having respiratory distress syndrome
Journal: The Cochrane database of systematic reviews
Treatment Used: Inositol
Number of Patients: 1177
Published — July 09, 2019

The objective of the study was to assess the effectiveness and safety of inositol in preterm infants with or without respiratory distress syndrome (RDS) in reducing adverse neonatal outcomes.

Condition: Prevention of Patent Ductus Arteriosus (PDA) in Preterm and/or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Ibuprofen
Number of Patients: 0
Published — June 22, 2019

This review of the literature determined the effectiveness and safety of ibuprofen compared to placebo/no intervention, or other cyclo-oxygenase inhibitor drugs in the prevention of patent ductus arteriosus (hole in heart; PDA) in preterm infants.

Condition: Preterm or Low Birth Weight Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Late Erythropoiesis-Stimulating Agents (ESAs): Darbepoetin (Darbe) and EPO
Number of Patients: 1651
Published — February 19, 2019

This review of the literature assessed the effectiveness and safety of late initiation of erythropoiesis-stimulating agents (ESAs), between eight and 28 days after birth, in reducing the use of red blood cell (RBC) transfusions in preterm or low birth weight infants.

Condition: Patent Ductus Arteriosus (PDA) in Preterm or Low Birth Weight (or Both) Infants
Journal: The Cochrane database of systematic reviews
Treatment Used: Ibuprofen
Number of Patients: 2843
Published — September 29, 2018

This review of the literature determined the the effectiveness and safety of ibuprofen compared with indomethacin, other cyclo-oxygenase inhibitor(s), placebo, or no intervention for closing a patent ductus arteriosus (hole between major arteries in the heart; PDA) in preterm, low-birth-weight, or preterm and low-birth-weight infants.